Rhumbline Advisers Celldex Therapeutics, Inc. Transaction History

Rhumbline Advisers

  • $104 Billion
  • Q1 2025

A detailed history of Rhumbline Advisers transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 98,266 shares of CLDX stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,266
Previous 91,939 6.88%
Holding current value
$1.8 Million
Previous $2.32 Million 15.71%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 08, 2025
BUY
$18.15 - $27.6 $114,835 - $174,625
6,327 Added 6.88%
98,266 $1.96 Million
Q4 2024

Jan 30, 2025
SELL
$23.31 - $32.4 $15,151 - $21,060
-650 Reduced 0.7%
91,939 $2.32 Million
Q3 2024

Nov 12, 2024
SELL
$32.06 - $44.56 $124,745 - $173,382
-3,891 Reduced 4.03%
92,589 $3.15 Million
Q2 2024

Aug 01, 2024
SELL
$32.76 - $42.56 $67,158 - $87,248
-2,050 Reduced 2.08%
96,480 $3.57 Million
Q1 2024

May 09, 2024
BUY
$35.22 - $51.88 $792,731 - $1.17 Million
22,508 Added 29.61%
98,530 $4.14 Million
Q4 2023

Feb 08, 2024
SELL
$22.61 - $40.65 $14,741 - $26,503
-652 Reduced 0.85%
76,022 $3.02 Million
Q3 2023

Nov 09, 2023
BUY
$25.45 - $37.46 $79,429 - $116,912
3,121 Added 4.24%
76,674 $2.11 Million
Q2 2023

Aug 08, 2023
SELL
$30.29 - $38.28 $11,237 - $14,201
-371 Reduced 0.5%
73,553 $2.5 Million
Q1 2023

May 11, 2023
BUY
$34.78 - $47.43 $70,116 - $95,618
2,016 Added 2.8%
73,924 $2.66 Million
Q4 2022

Feb 14, 2023
BUY
$27.78 - $45.38 $42,586 - $69,567
1,533 Added 2.18%
71,908 $3.21 Million
Q3 2022

Nov 10, 2022
BUY
$22.7 - $37.57 $122,965 - $203,516
5,417 Added 8.34%
70,375 $1.98 Million
Q2 2022

Aug 11, 2022
BUY
$20.5 - $37.33 $261,149 - $475,546
12,739 Added 24.4%
64,958 $1.75 Million
Q1 2022

May 12, 2022
BUY
$27.64 - $39.32 $66,225 - $94,210
2,396 Added 4.81%
52,219 $1.78 Million
Q4 2021

Feb 10, 2022
BUY
$35.68 - $56.27 $19,909 - $31,398
558 Added 1.13%
49,823 $1.93 Million
Q3 2021

Nov 12, 2021
BUY
$28.95 - $55.99 $244,048 - $471,995
8,430 Added 20.64%
49,265 $2.66 Million
Q2 2021

Aug 05, 2021
BUY
$20.71 - $35.37 $845,692 - $1.44 Million
40,835 New
40,835 $1.37 Million

Others Institutions Holding CLDX

# of Institutions
199
Shares Held
60.8M
Call Options Held
960K
Put Options Held
675K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $856M
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email